No photo of Thomas V O'Halloran

View Scopus Profile

Thomas V O'Halloran

  • 17720 Citations
1978 …2024
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Education/Academic qualification

Bioinorganic Chemistry, PhD, Columbia University

… → 1985

Bioinorganic Chemistry, MA, University of Missouri, Columbia

… → 1980

Chemistry, BS, University of Missouri, Columbia

… → 1979

Fingerprint Dive into the research topics where Thomas V O'Halloran is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Copper Medicine & Life Sciences
Zinc Medicine & Life Sciences
Metals Medicine & Life Sciences
Metallochaperones Medicine & Life Sciences
Proteins Medicine & Life Sciences
Ions Medicine & Life Sciences
Superoxide Dismutase Medicine & Life Sciences
Mercury Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1998 2024

Driving Biomedical Projects (DBP) - Resource for Quantitative Elemental Mapping for the Life Sciences

O'Halloran, T. V.

National Institute of General Medical Sciences

12/1/19 → 11/30/24

Project: Research project

Chemical elements
Metals
Cells
Physiology
Biomarkers

TR&D1 - Resource for Quantitative Elemental Mapping for the Life Sciences

O'Halloran, T. V.

National Institute of General Medical Sciences

12/1/19 → 11/30/24

Project: Research project

Chemical elements
Metals
Cells
Physiology
Biomarkers

Laser Ablation Inductively Coupled Plasma Time-of-Flight Mass Spectrometer for Advanced Bioelement Imaging Applications

O'Halloran, T. V.

Office of the Director, National Institutes of Health

8/1/19 → 7/31/22

Project: Research project

mass spectrometers
laser ablation
ablation
inductively coupled plasma mass spectrometry
acquisition

Mechanisms of Cadmium Induced Dysglycemia and Type 2 Diabetes Mellitus

Allen, N. B., El Muayed, M. & O'Halloran, T. V.

National Institute of Environmental Health Sciences

9/15/17 → 5/31/22

Project: Research project

Cadmium
Type 2 Diabetes Mellitus
Insulin
Prediabetic State
Reticulum

Metalloregulation by MerR and Fur Protein Families

Bleher, R. & O'Halloran, T. V.

National Institute of General Medical Sciences

1/1/17 → 11/30/20

Project: Research project

Metals
Physiology
Proteins
Metal ions
Escherichia coli

Research Output 1978 2019

3 Citations (Scopus)

Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent

Miodragović, D., Merlino, A., Swindell, E. P., Bogachkov, A., Ahn, R. W., Abuhadba, S., Ferraro, G., Marzo, T., Mazar, A. P., Messori, L. & O'Halloran, T. V., Apr 24 2019, In : Journal of the American Chemical Society. 141, 16, p. 6453-6457 5 p.

Research output: Contribution to journal › Article

Antineoplastic Agents
DNA
Arsenic
Cisplatin
Tumors
1 Citation (Scopus)

Bovine eggs release zinc in response to parthenogenetic and sperm-induced egg activation

Que, E. L., Duncan, F. E., Lee, H. C., Hornick, J. E., Vogt, S., Fissore, R. A., O'Halloran, T. V. & Woodruff, T. K., Mar 15 2019, In : Theriogenology. 127, p. 41-48 8 p.

Research output: Contribution to journal › Article

Eggs
Ovum
Spermatozoa
Zinc
zinc

Interrogating Intracellular Zinc Chemistry with a Long Stokes Shift Zinc Probe ZincBY-4

Garwin, S. A., Kelley, M. S., Sue, A. C., Que, E. L., Schatz, G. C., Woodruff, T. K. & O'Halloran, T. V., Jan 1 2019, In : Journal of the American Chemical Society. 141, 42, p. 16696-16705 10 p.

Research output: Contribution to journal › Article

Zinc
Imaging techniques
Poisons
Proxy
Fluorescein
1 Citation (Scopus)

Physicochemical mechanotransduction alters nuclear shape and mechanics via heterochromatin formation

Stephens, A. D., Liu, P. Z., Kandula, V., Chen, H., Almassalha, L. M., Herman, C., Backman, V., O'Halloran, T., Adam, S. A., Goldman, R. D., Banigan, E. J. & Marko, J. F., Aug 1 2019, In : Molecular biology of the cell. 30, 17, p. 2320-2330 11 p.

Research output: Contribution to journal › Article

Open Access
Heterochromatin
Mechanics
Chromatin
Ion Channels
Cations
1 Citation (Scopus)

Whole-body imaging of cell death provides a systemic, minimally invasive, dynamic, and near-real time indicator for chemotherapeutic drug toxicity

Johnson, S. E., Ugolkov, A., Haney, C. R., Bondarenko, G., Li, L., Waters, E. A., Bergan, R., Tran, A., O'Halloran, T. V., Mazar, A. & Zhao, M., Feb 15 2019, In : Clinical Cancer Research. 25, 4, p. 1331-1342 12 p.

Research output: Contribution to journal › Article

Whole Body Imaging
Drug-Related Side Effects and Adverse Reactions
Cell Death
Drug Therapy
Toxicology